An Exploratory Investigation to Identify if Dame Product's "DLM" Works to Improve Sexual Desire and Mood in Females

Dame Products

Status

Completed

Conditions

Sexual Desire Disorder

Treatments

Dietary Supplement: DLM - Test product

Study type

Interventional

Funder types

Industry

Identifiers

NCT05130411

20217-Dame

Details and patient eligibility

About

This is a single-group, non-randomized, non-controlled, open-label observational trial to study and evaluate the efficacy of a commercial dietary supplement, called "DLM" ("test product"). It is hypothesized that the test product, which is designed as an edible gummy, will present a favorable result to increase sexual desire and improve mood.

Enrollment

55 patients

Sex

Female

Ages

24 to 65 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

Females between 24-65 of age
Must be in good health (don't report any medical conditions asked in the screening questionnaire)
Experience sexuality-related personal distress (established in an online-screening questionnaire)
Experience a regular menstrual cycle
In the subject's opinion, previously experienced "normal sexual desire"
Self-reported stress in their daily lives
My present with self-reported anxiety
Trouble being present in the moment
Consider themselves as being busy all the time

Exclusion criteria

Current urinary or vaginal infection
Vaginal prolapse and any other disease that could interfere with the study conduction and participation
Diagnosis of depression
Diagnosis of anxiety
Currently experiencing significant symptoms of a mental disorder that might interfere with study participation (e.g. eating disorder, obsessive-compulsive disorder, posttraumatic stress syndrome, bipolar disorder)
Current substance abuse disorder
Diagnosis of an autoimmune disease, such as multiples sclerosis and rheumatoid arthritis
Self-reported or diagnosed hypotension (BP < 90 over 60)
Is currently using, or has used any of the following types of medication within 6 months of screening:

Any for of antidepressants; Mood stabilizers Benzodiazepines ("tranquillizers") Cognitive enhancers or stimulants (e.g. Adderall) The following contraception: Hormonal combination birth control pill; hormonal progesterone-only birth control pill; birth control patch; NuvaRing; Nexplanon Taking insulin or other diabetes medication

Currently, or in the past 6 months, undergoing hormone therapy
Any medical condition that is unstable or uncontrolled
A history of sexual trauma or abuse
Females that are pregnant, want to become pregnant for the duration of the study, or who are breastfeeding